The D285N and A549T substitutions in HSV gB described earlier as “hyperactive mutations” [59] conferred to an HER2-retargeted o-HSV an enhanced cell-to-cell spread in B16-HER2 murine cancer cells. Here, ERBB2 is linked to cancer.